ABOUT THERMO FISHER SCIENTIFIC
Thermo Fisher Scientific provides industry-leading pharma services for drug development, clinical trial logistics, and commercial manufacturing. We partner with customers in the pharmaceutical, biotech, and life sciences industries as their trusted CDMO to deliver medicine to patients faster. With more than 60 facilities around the world, we provide end-to-end pharma services across all phases of development and commercial manufacturing, including API, oral solid dose, biologics, cell therapy, mRNA, viral vectors, formulation, clinical trial solutions, logistics services and packaging. We couple our scientific and technical excellence in these areas with a strategic partnership to provide customers of all sizes access to a global network of facilities and dedicated experts across the Americas, Europe, Asia, and Australia. Through our integrated service offerings, we provide tailored solutions to fit your unique drug development journey, accelerating your time to market.
INDUSTRY INSIGHTS
-
See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.
-
Discover how localized oral solid dose development and manufacturing in Europe can help pharmaceutical companies navigate regulatory complexity, strengthen supply chains, and scale efficiently to meet market demands.
-
Explore how predictive modeling and in silico strategies can turn complex data into actionable insights that accelerate drug development and reduce risk across the development lifecycle.
-
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.
-
Drawing on experience from hundreds of successful transfers, our experts recognize that informed decision-making at critical junctures can determine whether a program maintains momentum or loses it.
-
From early formulation challenges to scale-up and commercial readiness, proactive planning and integrated capabilities help teams anticipate risks, accelerate decision-making, and maintain momentum across development.
CONTACT INFORMATION
Thermo Fisher Scientific
168 Third Avenue
Waltham, MA 02451
UNITED STATES
Phone: +1 781-622-1000
PATHEON PHARMA SERVICES SALES INQUIRIES
SOLUTIONS
-
In silico modeling technologies are transforming drug development and manufacturing by enhancing efficiency, accuracy, to allow innovations.
-
Small molecule drugs are chemical compounds that have a low molecular weight, typically below 900 daltons. Due to their small size and chemical characteristics, small molecule drugs are well-suited to enter the gastrointestinal tract and quickly absorb into the bloodstream. Additionally, they can easily pass through cell membranes to exert their therapeutic effects. Today it’s estimated that small molecules account for 90% of drugs in the market. One reason they’re so popular and patient-friendly is that they can be taken orally, which makes them convenient for all ages.